ArticleJournal of personalized medicine2024

Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience.

Alexandra-Diana Diaconu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.